Vertex executives warned that Casgevy, its curative treatment for sickle cell disease, would be slow to reach patients. But ...
The incidence of severe maternal morbidity remains high among patients with sickle cell disease, but a novel risk calculator ...
New data challenge common beliefs about antihistamines, corticosteroids, and vaccines in chronic urticaria, with practical ...
Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to ...
A detailed analysis of immune cells in Long COVID patients has revealed a previously unknown molecular signature linked to ...
Right after I told you it wasn't worth switching my cell phone carrier, I switched. I knew that Consumer Cellular is touted ...
As you can imagine our districts have been struggling … in the face of persistent inflation and costs like insurance and ...
In November 2023, the UK became the first country in the world to authorise a Crispr gene-editing therapy.
Vodacom, MTN, and Cell C say they are scrutinising new regulations from ICASA that govern voice, SMS, and data bundles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results